Pacific Edge Limited (PFGTF)
USD 0.08
(-28.57%)
USD 0.08
(-28.57%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 10.82 Million NZD | 24.35% |
| 2023 | 5.09 Million NZD | 6.52% |
| 2022 | 4.78 Million NZD | 12.52% |
| 2021 | 4.25 Million NZD | 48.77% |
| 2020 | 2.85 Million NZD | 7.68% |
| 2019 | 2.65 Million USD | -12.2% |
| 2018 | 3.02 Million USD | 10.64% |
| 2017 | 2.73 Million USD | 56.05% |
| 2016 | 1.75 Million USD | 21.09% |
| 2015 | 1.44 Million NZD | 74.92% |
| 2014 | 827.15 Thousand NZD | 6.91% |
| 2013 | 773.7 Thousand NZD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 6.84 Million USD | 36.14% |
| 2024 Q4 | 11.8 Million USD | -0.0% |
| 2024 Q1 | 4.88 Million USD | -2.43% |
| 2024 FY | 10.82 Million NZD | 112.3% |
| 2024 Q2 | 4.76 Million USD | 0.0% |
| 2023 Q3 | 5.17 Million USD | 16.9% |
| 2023 FY | 5.09 Million NZD | 6.52% |
| 2023 Q4 | 5.09 Million NZD | -1.46% |
| 2023 Q2 | 4.42 Million USD | 0.0% |
| 2022 FY | 4.78 Million NZD | 12.52% |
| 2022 Q2 | 4.53 Million USD | 0.0% |
| 2022 Q4 | 4.78 Million USD | 0.0% |
| 2021 Q4 | 4.25 Million USD | 0.0% |
| 2021 FY | 4.25 Million NZD | 48.77% |
| 2021 Q2 | 4.3 Million USD | 0.0% |
| 2020 Q4 | 2.85 Million USD | 0.0% |
| 2020 FY | 2.85 Million NZD | 7.68% |
| 2020 Q2 | 3.05 Million USD | 0.0% |
| 2019 FY | 2.65 Million USD | -12.2% |
| 2018 FY | 3.02 Million USD | 10.64% |
| 2017 FY | 2.73 Million USD | 56.05% |
| 2016 FY | 1.75 Million USD | 21.09% |
| 2015 FY | 1.44 Million NZD | 74.92% |
| 2014 FY | 827.15 Thousand NZD | 6.91% |
| 2013 FY | 773.7 Thousand NZD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | -200.055% |
| Arrayit Corporation | 7.49 Million USD | -44.412% |
| Atlantic International Corp. | 3.82 Million USD | -182.765% |
| Biocept, Inc. | 22.01 Million USD | 50.82% |
| Bioqual, Inc. | 18.93 Million USD | 42.834% |
| CardioGenics Holdings Inc | 1.79 Million USD | -503.146% |
| DermTech, Inc. | 64.75 Million USD | 83.282% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | 98.527% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | 12.595% |
| iMD Companies, Inc. | 1.67 Million USD | -546.631% |
| IDenta Corp. | 1.01 Million USD | -968.54% |
| Interpace Biosciences, Inc. | 28.15 Million USD | 61.551% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -3533.532% |
| InVitro International | 78.99 Thousand USD | -13605.532% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | 45.126% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -8272.971% |
| Medical Imaging Corp. | 9.51 Million USD | -13.753% |
| NovelStem International Corp. | 4.2 Million USD | -157.389% |
| Optigenex Inc. | 9.57 Million USD | -13.117% |
| PharmChem, Inc. | 558.64 Thousand USD | -1837.896% |
| Proteome Sciences plc | 18.48 Million USD | 41.446% |
| Response Genetics, Inc | 15.86 Million USD | 31.77% |
| Rennova Health, Inc. | 49.66 Million USD | 78.203% |
| RushNet, Inc. | 6.23 Million USD | -73.522% |
| ScreenPro Security Inc. | 1.6 Million USD | -576.377% |
| Stella Diagnostics Inc. | 18 Million USD | 39.874% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | -31.96% |
| Todos Medical Ltd. | 50.15 Million USD | 78.416% |